The global Artificial Organs and Bionics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
In terms of production side, this report researches the Artificial Organs and Bionics production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Artificial Organs and Bionics by regions (countries) and by Application.
The global Artificial Organs and Bionics market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Artificial Organs and Bionics market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Artificial Organs and Bionics markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Artificial Organs and Bionics market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Artificial Organs and Bionics market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Artificial Organs and Bionics market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Artificial Organs and Bionics market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Artificial Organs and Bionics market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Artificial Organs and Bionics market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Artificial Organs and Bionics market by each application segment for the same period.
This report includes the following manufacturers:
Edwards Lifesciences
LifeNet Health
Sonova
Orthofix Holdings
BionX Medical Technologies
Medtronic
Ekso Bionics
Gambro AB
Cochlear
HeartWare
SynCardia
Nipro Corporation
Ottobock
Berlin Heart GmbH
Baxter International
Boston Scientific Corporation
Zimmer Biomet
Market Segment by Type
Artificial Heart
Artificial Kidney
Artificial Liver
Artificial Pancreas
Artificial Lungs
Ventricular Assist Device
Cochlear Implant
Bionic Hand
Bionic Limb
Other
Market Segment by Application
Hospitals
Clinical Research Institutions
Academic Center
Other
Research Methodology
To compile the detailed study of the global Artificial Organs and Bionics market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Artificial Organs and Bionics market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Artificial Organs and Bionics market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
In terms of production side, this report researches the Artificial Organs and Bionics production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Artificial Organs and Bionics by regions (countries) and by Application.
The global Artificial Organs and Bionics market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Artificial Organs and Bionics market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Artificial Organs and Bionics markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Artificial Organs and Bionics market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Artificial Organs and Bionics market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Artificial Organs and Bionics market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Artificial Organs and Bionics market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Artificial Organs and Bionics market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Artificial Organs and Bionics market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Artificial Organs and Bionics market by each application segment for the same period.
This report includes the following manufacturers:
Edwards Lifesciences
LifeNet Health
Sonova
Orthofix Holdings
BionX Medical Technologies
Medtronic
Ekso Bionics
Gambro AB
Cochlear
HeartWare
SynCardia
Nipro Corporation
Ottobock
Berlin Heart GmbH
Baxter International
Boston Scientific Corporation
Zimmer Biomet
Market Segment by Type
Artificial Heart
Artificial Kidney
Artificial Liver
Artificial Pancreas
Artificial Lungs
Ventricular Assist Device
Cochlear Implant
Bionic Hand
Bionic Limb
Other
Market Segment by Application
Hospitals
Clinical Research Institutions
Academic Center
Other
Research Methodology
To compile the detailed study of the global Artificial Organs and Bionics market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Artificial Organs and Bionics market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Artificial Organs and Bionics market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Artificial Organs and Bionics Market Size Growth Rate by Type
1.2.2 Artificial Heart
1.2.3 Artificial Kidney
1.2.4 Artificial Liver
1.2.5 Artificial Pancreas
1.2.6 Artificial Lungs
1.2.7 Ventricular Assist Device
1.2.8 Cochlear Implant
1.2.9 Bionic Hand
1.2.10 Bionic Limb
1.2.11 Other
1.3 Market Segment by Application
1.3.1 Global Artificial Organs and Bionics Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Hospitals
1.3.3 Clinical Research Institutions
1.3.4 Academic Center
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Artificial Organs and Bionics Market Size (2016-2027)
2.1.1 Global Artificial Organs and Bionics Revenue (2016-2027)
2.1.2 Global Artificial Organs and Bionics Sales (2016-2027)
2.2 Global Artificial Organs and Bionics Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Artificial Organs and Bionics Sales by Regions (2016-2021)
2.2.2 Global Artificial Organs and Bionics Revenue by Regions (2016-2021)
2.3 Global Artificial Organs and Bionics Market Size Forecast by Region
2.3.1 Global Artificial Organs and Bionics Sales Forecast by Region (2022-2027)
2.3.2 Global Artificial Organs and Bionics Revenue Forecast by Region (2022-2027)
2.4 Global Top Artificial Organs and Bionics Regions (Countries) Ranking by Market Size
2.5 Artificial Organs and Bionics Industry Trends
2.5.1 Artificial Organs and Bionics Market Trends
2.5.2 Artificial Organs and Bionics Market Drivers
2.5.3 Artificial Organs and Bionics Market Challenges
2.5.4 Artificial Organs and Bionics Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Artificial Organs and Bionics Manufacturers by Sales (2016-2021)
3.1.1 Global Artificial Organs and Bionics Sales by Manufacturers (2016-2021)
3.1.2 Global Artificial Organs and Bionics Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Artificial Organs and Bionics Sales in 2020
3.2 Global Top Manufacturers Artificial Organs and Bionics by Revenue
3.2.1 Global Artificial Organs and Bionics Revenue by Manufacturers (2016-2021)
3.2.2 Top Artificial Organs and Bionics Manufacturers Covered: Ranking by Revenue
3.2.3 Global Artificial Organs and Bionics Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Artificial Organs and Bionics Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Artificial Organs and Bionics as of 2020)
3.4 Global Artificial Organs and Bionics Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Artificial Organs and Bionics Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Artificial Organs and Bionics Market
3.7 Key Manufacturers Artificial Organs and Bionics Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Artificial Organs and Bionics Market Size by Type
4.1 Global Artificial Organs and Bionics Historic Market Review by Type (2016-2021)
4.1.1 Global Artificial Organs and Bionics Sales Market Share by Type (2016-2021)
4.1.2 Global Artificial Organs and Bionics Revenue Market Share by Type (2016-2021)
4.1.3 Artificial Organs and Bionics Price by Type (2016-2021)
4.2 Global Artificial Organs and Bionics Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Artificial Organs and Bionics Sales Forecast by Type (2022-2027)
4.2.2 Global Artificial Organs and Bionics Revenue Forecast by Type (2022-2027)
4.2.3 Artificial Organs and Bionics Price Forecast by Type (2022-2027)
5 Global Artificial Organs and Bionics Market Size by Application
5.1 Global Artificial Organs and Bionics Historic Market Review by Application (2016-2021)
5.1.1 Global Artificial Organs and Bionics Sales Market Share by Application (2016-2021)
5.1.2 Global Artificial Organs and Bionics Revenue Market Share by Application (2016-2021)
5.1.3 Artificial Organs and Bionics Price by Application (2016-2021)
5.2 Global Artificial Organs and Bionics Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Artificial Organs and Bionics Sales Forecast by Application (2022-2027)
5.2.2 Global Artificial Organs and Bionics Revenue Forecast by Application (2022-2027)
5.2.3 Artificial Organs and Bionics Price Forecast by Application (2022-2027)
6 North America
6.1 North America Artificial Organs and Bionics Sales Breakdown by Company
6.1.1 North America Artificial Organs and Bionics Sales by Company (2016-2027)
6.1.2 North America Artificial Organs and Bionics Revenue by Company (2016-2027)
6.2 North America Artificial Organs and Bionics Market Size by Type (2016-2027)
6.2.1 North America Artificial Organs and Bionics Sales by Type (2016-2027)
6.2.2 North America Artificial Organs and Bionics Revenue by Type (2016-2027)
6.3 North America Artificial Organs and Bionics Market Size by Application (2016-2027)
6.3.1 North America Artificial Organs and Bionics Sales by Application (2016-2027)
6.3.2 North America Artificial Organs and Bionics Revenue by Application (2016-2027)
6.4 North America Artificial Organs and Bionics Market Size by Country
6.4.1 North America Artificial Organs and Bionics Sales by Country (2016-2027)
6.4.2 North America Artificial Organs and Bionics Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Artificial Organs and Bionics Sales Breakdown by Company
7.1.1 Europe Artificial Organs and Bionics Sales by Company (2016-2027)
7.1.2 Europe Artificial Organs and Bionics Revenue by Company (2016-2027)
7.2 Europe Artificial Organs and Bionics Market Size by Type (2016-2027)
7.2.1 Europe Artificial Organs and Bionics Sales by Type (2016-2027)
7.2.2 Europe Artificial Organs and Bionics Revenue by Type (2016-2027)
7.3 Europe Artificial Organs and Bionics Market Size by Application (2016-2027)
7.3.1 Europe Artificial Organs and Bionics Sales by Application (2016-2027)
7.3.2 Europe Artificial Organs and Bionics Revenue by Application (2016-2027)
7.4 Europe Artificial Organs and Bionics Market Size by Country
7.4.1 Europe Artificial Organs and Bionics Sales by Country (2016-2027)
7.4.2 Europe Artificial Organs and Bionics Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Artificial Organs and Bionics Sales Breakdown by Company
8.1.1 Asia Pacific Artificial Organs and Bionics Sales by Company (2016-2027)
8.1.2 Asia Pacific Artificial Organs and Bionics Revenue by Company (2016-2027)
8.2 Asia Pacific Artificial Organs and Bionics Market Size by Type (2016-2027)
8.2.1 Asia Pacific Artificial Organs and Bionics Sales by Type (2016-2027)
8.2.2 Asia Pacific Artificial Organs and Bionics Revenue by Type (2016-2027)
8.3 Asia Pacific Artificial Organs and Bionics Market Size by Application (2016-2027)
8.3.1 Asia Pacific Artificial Organs and Bionics Sales by Application (2016-2027)
8.3.2 Asia Pacific Artificial Organs and Bionics Revenue by Application (2016-2027)
8.4 Asia Pacific Artificial Organs and Bionics Market Size by Regions
8.4.1 Asia Pacific Artificial Organs and Bionics Sales by Regions
8.4.2 Asia Pacific Artificial Organs and Bionics Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Artificial Organs and Bionics Sales Breakdown by Company
9.1.1 Latin America Artificial Organs and Bionics Sales by Company (2016-2027)
9.1.2 Latin America Artificial Organs and Bionics Revenue by Company (2016-2027)
9.2 Latin America Artificial Organs and Bionics Market Size by Type (2016-2027)
9.2.1 Latin America Artificial Organs and Bionics Sales by Type (2016-2027)
9.2.2 Latin America Artificial Organs and Bionics Revenue by Type (2016-2027)
9.3 Latin America Artificial Organs and Bionics Market Size by Application (2016-2027)
9.3.1 Latin America Artificial Organs and Bionics Sales by Application (2016-2027)
9.3.2 Latin America Artificial Organs and Bionics Revenue by Application (2016-2027)
9.4 Latin America Artificial Organs and Bionics Market Size by Country
9.4.1 Latin America Artificial Organs and Bionics Sales by Country (2016-2027)
9.4.2 Latin America Artificial Organs and Bionics Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Artificial Organs and Bionics Sales Breakdown by Company
10.1.1 Middle East and Africa Artificial Organs and Bionics Sales by Company (2016-2027)
10.1.2 Middle East and Africa Artificial Organs and Bionics Revenue by Company (2016-2027)
10.2 Middle East and Africa Artificial Organs and Bionics Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Artificial Organs and Bionics Sales by Type (2016-2027)
10.2.2 Middle East and Africa Artificial Organs and Bionics Revenue by Type (2016-2027)
10.3 Middle East and Africa Artificial Organs and Bionics Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Artificial Organs and Bionics Sales by Application (2016-2027)
10.3.2 Middle East and Africa Artificial Organs and Bionics Revenue by Application (2016-2027)
10.4 Middle East and Africa Artificial Organs and Bionics Market Size by Country
10.4.1 Middle East and Africa Artificial Organs and Bionics Sales by Country (2016-2027)
10.4.2 Middle East and Africa Artificial Organs and Bionics Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Edwards Lifesciences
11.1.1 Edwards Lifesciences Corporation Information
11.1.2 Edwards Lifesciences Overview
11.1.3 Edwards Lifesciences Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Edwards Lifesciences Artificial Organs and Bionics Products and Services
11.1.5 Edwards Lifesciences Artificial Organs and Bionics SWOT Analysis
11.1.6 Edwards Lifesciences Recent Developments
11.2 LifeNet Health
11.2.1 LifeNet Health Corporation Information
11.2.2 LifeNet Health Overview
11.2.3 LifeNet Health Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 LifeNet Health Artificial Organs and Bionics Products and Services
11.2.5 LifeNet Health Artificial Organs and Bionics SWOT Analysis
11.2.6 LifeNet Health Recent Developments
11.3 Sonova
11.3.1 Sonova Corporation Information
11.3.2 Sonova Overview
11.3.3 Sonova Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Sonova Artificial Organs and Bionics Products and Services
11.3.5 Sonova Artificial Organs and Bionics SWOT Analysis
11.3.6 Sonova Recent Developments
11.4 Orthofix Holdings
11.4.1 Orthofix Holdings Corporation Information
11.4.2 Orthofix Holdings Overview
11.4.3 Orthofix Holdings Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Orthofix Holdings Artificial Organs and Bionics Products and Services
11.4.5 Orthofix Holdings Artificial Organs and Bionics SWOT Analysis
11.4.6 Orthofix Holdings Recent Developments
11.5 BionX Medical Technologies
11.5.1 BionX Medical Technologies Corporation Information
11.5.2 BionX Medical Technologies Overview
11.5.3 BionX Medical Technologies Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 BionX Medical Technologies Artificial Organs and Bionics Products and Services
11.5.5 BionX Medical Technologies Artificial Organs and Bionics SWOT Analysis
11.5.6 BionX Medical Technologies Recent Developments
11.6 Medtronic
11.6.1 Medtronic Corporation Information
11.6.2 Medtronic Overview
11.6.3 Medtronic Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Medtronic Artificial Organs and Bionics Products and Services
11.6.5 Medtronic Artificial Organs and Bionics SWOT Analysis
11.6.6 Medtronic Recent Developments
11.7 Ekso Bionics
11.7.1 Ekso Bionics Corporation Information
11.7.2 Ekso Bionics Overview
11.7.3 Ekso Bionics Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Ekso Bionics Artificial Organs and Bionics Products and Services
11.7.5 Ekso Bionics Artificial Organs and Bionics SWOT Analysis
11.7.6 Ekso Bionics Recent Developments
11.8 Gambro AB
11.8.1 Gambro AB Corporation Information
11.8.2 Gambro AB Overview
11.8.3 Gambro AB Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Gambro AB Artificial Organs and Bionics Products and Services
11.8.5 Gambro AB Artificial Organs and Bionics SWOT Analysis
11.8.6 Gambro AB Recent Developments
11.9 Cochlear
11.9.1 Cochlear Corporation Information
11.9.2 Cochlear Overview
11.9.3 Cochlear Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Cochlear Artificial Organs and Bionics Products and Services
11.9.5 Cochlear Artificial Organs and Bionics SWOT Analysis
11.9.6 Cochlear Recent Developments
11.10 HeartWare
11.10.1 HeartWare Corporation Information
11.10.2 HeartWare Overview
11.10.3 HeartWare Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 HeartWare Artificial Organs and Bionics Products and Services
11.10.5 HeartWare Artificial Organs and Bionics SWOT Analysis
11.10.6 HeartWare Recent Developments
11.11 SynCardia
11.11.1 SynCardia Corporation Information
11.11.2 SynCardia Overview
11.11.3 SynCardia Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 SynCardia Artificial Organs and Bionics Products and Services
11.11.5 SynCardia Recent Developments
11.12 Nipro Corporation
11.12.1 Nipro Corporation Corporation Information
11.12.2 Nipro Corporation Overview
11.12.3 Nipro Corporation Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Nipro Corporation Artificial Organs and Bionics Products and Services
11.12.5 Nipro Corporation Recent Developments
11.13 Ottobock
11.13.1 Ottobock Corporation Information
11.13.2 Ottobock Overview
11.13.3 Ottobock Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 Ottobock Artificial Organs and Bionics Products and Services
11.13.5 Ottobock Recent Developments
11.14 Berlin Heart GmbH
11.14.1 Berlin Heart GmbH Corporation Information
11.14.2 Berlin Heart GmbH Overview
11.14.3 Berlin Heart GmbH Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.14.4 Berlin Heart GmbH Artificial Organs and Bionics Products and Services
11.14.5 Berlin Heart GmbH Recent Developments
11.15 Baxter International
11.15.1 Baxter International Corporation Information
11.15.2 Baxter International Overview
11.15.3 Baxter International Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.15.4 Baxter International Artificial Organs and Bionics Products and Services
11.15.5 Baxter International Recent Developments
11.16 Boston Scientific Corporation
11.16.1 Boston Scientific Corporation Corporation Information
11.16.2 Boston Scientific Corporation Overview
11.16.3 Boston Scientific Corporation Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.16.4 Boston Scientific Corporation Artificial Organs and Bionics Products and Services
11.16.5 Boston Scientific Corporation Recent Developments
11.17 Zimmer Biomet
11.17.1 Zimmer Biomet Corporation Information
11.17.2 Zimmer Biomet Overview
11.17.3 Zimmer Biomet Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.17.4 Zimmer Biomet Artificial Organs and Bionics Products and Services
11.17.5 Zimmer Biomet Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Artificial Organs and Bionics Value Chain Analysis
12.2 Artificial Organs and Bionics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Artificial Organs and Bionics Production Mode & Process
12.4 Artificial Organs and Bionics Sales and Marketing
12.4.1 Artificial Organs and Bionics Sales Channels
12.4.2 Artificial Organs and Bionics Distributors
12.5 Artificial Organs and Bionics Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Artificial Organs and Bionics Market Size Growth Rate by Type
1.2.2 Artificial Heart
1.2.3 Artificial Kidney
1.2.4 Artificial Liver
1.2.5 Artificial Pancreas
1.2.6 Artificial Lungs
1.2.7 Ventricular Assist Device
1.2.8 Cochlear Implant
1.2.9 Bionic Hand
1.2.10 Bionic Limb
1.2.11 Other
1.3 Market Segment by Application
1.3.1 Global Artificial Organs and Bionics Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Hospitals
1.3.3 Clinical Research Institutions
1.3.4 Academic Center
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Artificial Organs and Bionics Market Size (2016-2027)
2.1.1 Global Artificial Organs and Bionics Revenue (2016-2027)
2.1.2 Global Artificial Organs and Bionics Sales (2016-2027)
2.2 Global Artificial Organs and Bionics Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Artificial Organs and Bionics Sales by Regions (2016-2021)
2.2.2 Global Artificial Organs and Bionics Revenue by Regions (2016-2021)
2.3 Global Artificial Organs and Bionics Market Size Forecast by Region
2.3.1 Global Artificial Organs and Bionics Sales Forecast by Region (2022-2027)
2.3.2 Global Artificial Organs and Bionics Revenue Forecast by Region (2022-2027)
2.4 Global Top Artificial Organs and Bionics Regions (Countries) Ranking by Market Size
2.5 Artificial Organs and Bionics Industry Trends
2.5.1 Artificial Organs and Bionics Market Trends
2.5.2 Artificial Organs and Bionics Market Drivers
2.5.3 Artificial Organs and Bionics Market Challenges
2.5.4 Artificial Organs and Bionics Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Artificial Organs and Bionics Manufacturers by Sales (2016-2021)
3.1.1 Global Artificial Organs and Bionics Sales by Manufacturers (2016-2021)
3.1.2 Global Artificial Organs and Bionics Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Artificial Organs and Bionics Sales in 2020
3.2 Global Top Manufacturers Artificial Organs and Bionics by Revenue
3.2.1 Global Artificial Organs and Bionics Revenue by Manufacturers (2016-2021)
3.2.2 Top Artificial Organs and Bionics Manufacturers Covered: Ranking by Revenue
3.2.3 Global Artificial Organs and Bionics Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Artificial Organs and Bionics Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Artificial Organs and Bionics as of 2020)
3.4 Global Artificial Organs and Bionics Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Artificial Organs and Bionics Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Artificial Organs and Bionics Market
3.7 Key Manufacturers Artificial Organs and Bionics Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Artificial Organs and Bionics Market Size by Type
4.1 Global Artificial Organs and Bionics Historic Market Review by Type (2016-2021)
4.1.1 Global Artificial Organs and Bionics Sales Market Share by Type (2016-2021)
4.1.2 Global Artificial Organs and Bionics Revenue Market Share by Type (2016-2021)
4.1.3 Artificial Organs and Bionics Price by Type (2016-2021)
4.2 Global Artificial Organs and Bionics Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Artificial Organs and Bionics Sales Forecast by Type (2022-2027)
4.2.2 Global Artificial Organs and Bionics Revenue Forecast by Type (2022-2027)
4.2.3 Artificial Organs and Bionics Price Forecast by Type (2022-2027)
5 Global Artificial Organs and Bionics Market Size by Application
5.1 Global Artificial Organs and Bionics Historic Market Review by Application (2016-2021)
5.1.1 Global Artificial Organs and Bionics Sales Market Share by Application (2016-2021)
5.1.2 Global Artificial Organs and Bionics Revenue Market Share by Application (2016-2021)
5.1.3 Artificial Organs and Bionics Price by Application (2016-2021)
5.2 Global Artificial Organs and Bionics Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Artificial Organs and Bionics Sales Forecast by Application (2022-2027)
5.2.2 Global Artificial Organs and Bionics Revenue Forecast by Application (2022-2027)
5.2.3 Artificial Organs and Bionics Price Forecast by Application (2022-2027)
6 North America
6.1 North America Artificial Organs and Bionics Sales Breakdown by Company
6.1.1 North America Artificial Organs and Bionics Sales by Company (2016-2027)
6.1.2 North America Artificial Organs and Bionics Revenue by Company (2016-2027)
6.2 North America Artificial Organs and Bionics Market Size by Type (2016-2027)
6.2.1 North America Artificial Organs and Bionics Sales by Type (2016-2027)
6.2.2 North America Artificial Organs and Bionics Revenue by Type (2016-2027)
6.3 North America Artificial Organs and Bionics Market Size by Application (2016-2027)
6.3.1 North America Artificial Organs and Bionics Sales by Application (2016-2027)
6.3.2 North America Artificial Organs and Bionics Revenue by Application (2016-2027)
6.4 North America Artificial Organs and Bionics Market Size by Country
6.4.1 North America Artificial Organs and Bionics Sales by Country (2016-2027)
6.4.2 North America Artificial Organs and Bionics Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Artificial Organs and Bionics Sales Breakdown by Company
7.1.1 Europe Artificial Organs and Bionics Sales by Company (2016-2027)
7.1.2 Europe Artificial Organs and Bionics Revenue by Company (2016-2027)
7.2 Europe Artificial Organs and Bionics Market Size by Type (2016-2027)
7.2.1 Europe Artificial Organs and Bionics Sales by Type (2016-2027)
7.2.2 Europe Artificial Organs and Bionics Revenue by Type (2016-2027)
7.3 Europe Artificial Organs and Bionics Market Size by Application (2016-2027)
7.3.1 Europe Artificial Organs and Bionics Sales by Application (2016-2027)
7.3.2 Europe Artificial Organs and Bionics Revenue by Application (2016-2027)
7.4 Europe Artificial Organs and Bionics Market Size by Country
7.4.1 Europe Artificial Organs and Bionics Sales by Country (2016-2027)
7.4.2 Europe Artificial Organs and Bionics Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Artificial Organs and Bionics Sales Breakdown by Company
8.1.1 Asia Pacific Artificial Organs and Bionics Sales by Company (2016-2027)
8.1.2 Asia Pacific Artificial Organs and Bionics Revenue by Company (2016-2027)
8.2 Asia Pacific Artificial Organs and Bionics Market Size by Type (2016-2027)
8.2.1 Asia Pacific Artificial Organs and Bionics Sales by Type (2016-2027)
8.2.2 Asia Pacific Artificial Organs and Bionics Revenue by Type (2016-2027)
8.3 Asia Pacific Artificial Organs and Bionics Market Size by Application (2016-2027)
8.3.1 Asia Pacific Artificial Organs and Bionics Sales by Application (2016-2027)
8.3.2 Asia Pacific Artificial Organs and Bionics Revenue by Application (2016-2027)
8.4 Asia Pacific Artificial Organs and Bionics Market Size by Regions
8.4.1 Asia Pacific Artificial Organs and Bionics Sales by Regions
8.4.2 Asia Pacific Artificial Organs and Bionics Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Artificial Organs and Bionics Sales Breakdown by Company
9.1.1 Latin America Artificial Organs and Bionics Sales by Company (2016-2027)
9.1.2 Latin America Artificial Organs and Bionics Revenue by Company (2016-2027)
9.2 Latin America Artificial Organs and Bionics Market Size by Type (2016-2027)
9.2.1 Latin America Artificial Organs and Bionics Sales by Type (2016-2027)
9.2.2 Latin America Artificial Organs and Bionics Revenue by Type (2016-2027)
9.3 Latin America Artificial Organs and Bionics Market Size by Application (2016-2027)
9.3.1 Latin America Artificial Organs and Bionics Sales by Application (2016-2027)
9.3.2 Latin America Artificial Organs and Bionics Revenue by Application (2016-2027)
9.4 Latin America Artificial Organs and Bionics Market Size by Country
9.4.1 Latin America Artificial Organs and Bionics Sales by Country (2016-2027)
9.4.2 Latin America Artificial Organs and Bionics Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Artificial Organs and Bionics Sales Breakdown by Company
10.1.1 Middle East and Africa Artificial Organs and Bionics Sales by Company (2016-2027)
10.1.2 Middle East and Africa Artificial Organs and Bionics Revenue by Company (2016-2027)
10.2 Middle East and Africa Artificial Organs and Bionics Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Artificial Organs and Bionics Sales by Type (2016-2027)
10.2.2 Middle East and Africa Artificial Organs and Bionics Revenue by Type (2016-2027)
10.3 Middle East and Africa Artificial Organs and Bionics Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Artificial Organs and Bionics Sales by Application (2016-2027)
10.3.2 Middle East and Africa Artificial Organs and Bionics Revenue by Application (2016-2027)
10.4 Middle East and Africa Artificial Organs and Bionics Market Size by Country
10.4.1 Middle East and Africa Artificial Organs and Bionics Sales by Country (2016-2027)
10.4.2 Middle East and Africa Artificial Organs and Bionics Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Edwards Lifesciences
11.1.1 Edwards Lifesciences Corporation Information
11.1.2 Edwards Lifesciences Overview
11.1.3 Edwards Lifesciences Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Edwards Lifesciences Artificial Organs and Bionics Products and Services
11.1.5 Edwards Lifesciences Artificial Organs and Bionics SWOT Analysis
11.1.6 Edwards Lifesciences Recent Developments
11.2 LifeNet Health
11.2.1 LifeNet Health Corporation Information
11.2.2 LifeNet Health Overview
11.2.3 LifeNet Health Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 LifeNet Health Artificial Organs and Bionics Products and Services
11.2.5 LifeNet Health Artificial Organs and Bionics SWOT Analysis
11.2.6 LifeNet Health Recent Developments
11.3 Sonova
11.3.1 Sonova Corporation Information
11.3.2 Sonova Overview
11.3.3 Sonova Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Sonova Artificial Organs and Bionics Products and Services
11.3.5 Sonova Artificial Organs and Bionics SWOT Analysis
11.3.6 Sonova Recent Developments
11.4 Orthofix Holdings
11.4.1 Orthofix Holdings Corporation Information
11.4.2 Orthofix Holdings Overview
11.4.3 Orthofix Holdings Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Orthofix Holdings Artificial Organs and Bionics Products and Services
11.4.5 Orthofix Holdings Artificial Organs and Bionics SWOT Analysis
11.4.6 Orthofix Holdings Recent Developments
11.5 BionX Medical Technologies
11.5.1 BionX Medical Technologies Corporation Information
11.5.2 BionX Medical Technologies Overview
11.5.3 BionX Medical Technologies Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 BionX Medical Technologies Artificial Organs and Bionics Products and Services
11.5.5 BionX Medical Technologies Artificial Organs and Bionics SWOT Analysis
11.5.6 BionX Medical Technologies Recent Developments
11.6 Medtronic
11.6.1 Medtronic Corporation Information
11.6.2 Medtronic Overview
11.6.3 Medtronic Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Medtronic Artificial Organs and Bionics Products and Services
11.6.5 Medtronic Artificial Organs and Bionics SWOT Analysis
11.6.6 Medtronic Recent Developments
11.7 Ekso Bionics
11.7.1 Ekso Bionics Corporation Information
11.7.2 Ekso Bionics Overview
11.7.3 Ekso Bionics Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 Ekso Bionics Artificial Organs and Bionics Products and Services
11.7.5 Ekso Bionics Artificial Organs and Bionics SWOT Analysis
11.7.6 Ekso Bionics Recent Developments
11.8 Gambro AB
11.8.1 Gambro AB Corporation Information
11.8.2 Gambro AB Overview
11.8.3 Gambro AB Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Gambro AB Artificial Organs and Bionics Products and Services
11.8.5 Gambro AB Artificial Organs and Bionics SWOT Analysis
11.8.6 Gambro AB Recent Developments
11.9 Cochlear
11.9.1 Cochlear Corporation Information
11.9.2 Cochlear Overview
11.9.3 Cochlear Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Cochlear Artificial Organs and Bionics Products and Services
11.9.5 Cochlear Artificial Organs and Bionics SWOT Analysis
11.9.6 Cochlear Recent Developments
11.10 HeartWare
11.10.1 HeartWare Corporation Information
11.10.2 HeartWare Overview
11.10.3 HeartWare Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 HeartWare Artificial Organs and Bionics Products and Services
11.10.5 HeartWare Artificial Organs and Bionics SWOT Analysis
11.10.6 HeartWare Recent Developments
11.11 SynCardia
11.11.1 SynCardia Corporation Information
11.11.2 SynCardia Overview
11.11.3 SynCardia Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 SynCardia Artificial Organs and Bionics Products and Services
11.11.5 SynCardia Recent Developments
11.12 Nipro Corporation
11.12.1 Nipro Corporation Corporation Information
11.12.2 Nipro Corporation Overview
11.12.3 Nipro Corporation Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Nipro Corporation Artificial Organs and Bionics Products and Services
11.12.5 Nipro Corporation Recent Developments
11.13 Ottobock
11.13.1 Ottobock Corporation Information
11.13.2 Ottobock Overview
11.13.3 Ottobock Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 Ottobock Artificial Organs and Bionics Products and Services
11.13.5 Ottobock Recent Developments
11.14 Berlin Heart GmbH
11.14.1 Berlin Heart GmbH Corporation Information
11.14.2 Berlin Heart GmbH Overview
11.14.3 Berlin Heart GmbH Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.14.4 Berlin Heart GmbH Artificial Organs and Bionics Products and Services
11.14.5 Berlin Heart GmbH Recent Developments
11.15 Baxter International
11.15.1 Baxter International Corporation Information
11.15.2 Baxter International Overview
11.15.3 Baxter International Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.15.4 Baxter International Artificial Organs and Bionics Products and Services
11.15.5 Baxter International Recent Developments
11.16 Boston Scientific Corporation
11.16.1 Boston Scientific Corporation Corporation Information
11.16.2 Boston Scientific Corporation Overview
11.16.3 Boston Scientific Corporation Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.16.4 Boston Scientific Corporation Artificial Organs and Bionics Products and Services
11.16.5 Boston Scientific Corporation Recent Developments
11.17 Zimmer Biomet
11.17.1 Zimmer Biomet Corporation Information
11.17.2 Zimmer Biomet Overview
11.17.3 Zimmer Biomet Artificial Organs and Bionics Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.17.4 Zimmer Biomet Artificial Organs and Bionics Products and Services
11.17.5 Zimmer Biomet Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Artificial Organs and Bionics Value Chain Analysis
12.2 Artificial Organs and Bionics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Artificial Organs and Bionics Production Mode & Process
12.4 Artificial Organs and Bionics Sales and Marketing
12.4.1 Artificial Organs and Bionics Sales Channels
12.4.2 Artificial Organs and Bionics Distributors
12.5 Artificial Organs and Bionics Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
